# A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters

> **NCT00395876** · PHASE3 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 100 (actual)

## Conditions studied

- Dysfunctional Central Venous Access Catheters

## Interventions

- **DRUG:** placebo
- **DRUG:** tenecteplase

## Key facts

- **NCT ID:** NCT00395876
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-06
- **Final completion:** —
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395876, "A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00395876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*